Emcure Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Emcure Pharmaceuticals has submitted a routine compliance filing confirming that it published its unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26) in two newspapers — Financial Express (English) and Loksatta (Marathi) — on August 8, 2025. This publication is being done as required under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The actual financial numbers are not part of this filing; investors need to look at the newspaper extracts or the company's website (www.emcure.com) for the detailed results. The letter was signed by Chetan Sharma, Company Secretary & Compliance Officer.
This is a routine regulatory disclosure with no material impact on the stock price. Investors seeking the actual quarterly performance numbers should refer to the published financial results or the company's website.